AJP - Heart Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Heart Circ Physiol 272: H2736-H2745, 1997;
0363-6135/97 $5.00
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pannen, B. H.
Right arrow Articles by Geiger, K. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pannen, B. H.
Right arrow Articles by Geiger, K. K.

AJP - Heart and Circulatory Physiology, Vol 272, Issue 6 2736-H2745, Copyright © 1997 by American Physiological Society


ARTICLES

Regulation of hepatic blood flow during resuscitation from hemorrhagic shock: role of NO and endothelins

B. H. Pannen, M. Bauer, G. F. Noldge-Schomburg, J. X. Zhang, J. L. Robotham, M. G. Clemens and K. K. Geiger
Department of Anesthesiology and Critical Care Medicine, University of Freiburg, Germany.

We determined the role of nitric oxide (NO) and endothelins (ETs) in the regulation of hepatic blood flow during resuscitation from hemorrhagic shock (HS) in anesthetized rats. Volume resuscitation restored systemic hemodynamics and increased hepatic arterial and portal venous flow above baseline in the vehicle group. Presence of N omega-nitro-L-arginine methyl ester (L-NAME, 1 mg/kg) during resuscitation increased systemic vascular resistance (SVR) above baseline, prevented the restoration of hepatic arterial flow, and abolished portal hyperemia. Although the ETA+B-receptor antagonist bosentan (10 mg/kg) did not alter the systemic hemodynamic response, it abolished the hepatic arterial and portal hyperemia. The ETA-receptor antagonist BQ-610 (150 micrograms/kg) reduced SVR below baseline, allowed hepatic arterial hyperemia to occur, and further enhanced the portal venous hyperemia. This indicates that 1) NO reduces SVR and acts to preserve hepatic blood flow during resuscitation from HS; 2) ETA-receptor-mediated vasoconstriction counteracts the systemic and portal hemodynamic effects of NO; and 3) simultaneous ETB-receptor stimulation enhances blood flow to the liver and may serve to modulate the ETA-receptor-mediated vasoconstrictive effects of ETs.


This article has been cited by other articles:


Home page
J. Appl. Physiol.Home page
J. G. Kiang, R. M. Peckham, L. E. Duke, T. Shimizu, I. H. Chaudry, and G. C. Tsokos
Androstenediol inhibits the trauma-hemorrhage-induced increase in caspase-3 by downregulating the inducible nitric oxide synthase pathway
J Appl Physiol, March 1, 2007; 102(3): 933 - 941.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
T. Shimizu, L. Szalay, M. A. Choudhry, M. G. Schwacha, L. W. Rue III, K. I. Bland, and I. H. Chaudry
Mechanism of salutary effects of androstenediol on hepatic function after trauma-hemorrhage: role of endothelial and inducible nitric oxide synthase
Am J Physiol Gastrointest Liver Physiol, February 1, 2005; 288(2): G244 - G250.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
H. Hendrickson, S. Chatterjee, S. Cao, M. M. Ruiz, W. C. Sessa, and V. Shah
Influence of caveolin on constitutively activated recombinant eNOS: insights into eNOS dysfunction in BDL rat liver
Am J Physiol Gastrointest Liver Physiol, August 8, 2003; 285(3): G652 - G660.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
B. H. J. Pannen
New Insights Into the Regulation of Hepatic Blood Flow After Ischemia and Reperfusion
Anesth. Analg., June 1, 2002; 94(6): 1448 - 1457.
[Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
B. H. J. Pannen, S. Schroll, T. Loop, M. Bauer, A. Hoetzel, and K. K. Geiger
Hemorrhagic shock primes the hepatic portal circulation for the vasoconstrictive effects of endothelin-1
Am J Physiol Heart Circ Physiol, September 1, 2001; 281(3): H1075 - H1084.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
E. P. Nadler, E. C. Dickinson, D. Beer-Stolz, S. M. Alber, S. C. Watkins, D. W. Pratt, and H. R. Ford
Scavenging nitric oxide reduces hepatocellular injury after endotoxin challenge
Am J Physiol Gastrointest Liver Physiol, July 1, 2001; 281(1): G173 - G181.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
V. Shah, A. F. Chen, S. Cao, H. Hendrickson, D. Weiler, L. Smith, J. Yao, and Z. S. Katusic
Gene transfer of recombinant endothelial nitric oxide synthase to liver in vivo and in vitro
Am J Physiol Gastrointest Liver Physiol, November 1, 2000; 279(5): G1023 - G1030.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online